These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 3487616)

  • 1. B cell stimulatory factor 1 (BSF-1) prepares resting B cells to enter S phase in response to anti-IgM and lipopolysaccharide.
    Rabin EM; Mond JJ; Ohara J; Paul WE
    J Exp Med; 1986 Aug; 164(2):517-31. PubMed ID: 3487616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B-cell stimulatory factor 1 activates resting B cells.
    Rabin EM; Ohara J; Paul WE
    Proc Natl Acad Sci U S A; 1985 May; 82(9):2935-9. PubMed ID: 3873071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Properties of anti-Lyb-2-mediated B-cell activation and the relationship between Lyb-2 molecules and receptors for B-cell stimulatory factor-1 on murine B lymphocytes.
    Subbarao B; Morris J; Baluyut AR
    Cell Immunol; 1988 Apr; 112(2):329-42. PubMed ID: 3281760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential regulation by Ly-5 and Lyb-2 of IgG production induced by lipopolysaccharide and B cell stimulatory factor-1 (IL-4).
    Yakura H; Kawabata I; Ashida T; Katagiri M
    J Immunol; 1988 Aug; 141(3):875-80. PubMed ID: 3260915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B cell stimulatory factor-1 (interleukin 4) prepares resting murine B cells to secrete IgG1 upon subsequent stimulation with bacterial lipopolysaccharide.
    Snapper CM; Paul WE
    J Immunol; 1987 Jul; 139(1):10-7. PubMed ID: 3495594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BSF-1 action on resting B cells does not require elevation of inositol phospholipid metabolism or increased [Ca2+]i.
    Mizuguchi J; Beaven MA; Ohara J; Paul WE
    J Immunol; 1986 Oct; 137(7):2215-9. PubMed ID: 3093568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LPS-activated CBA/N mouse B cells respond to anti-Ig and a BSF-1-like factor.
    Howard M; Pesavento P; Stein P
    J Immunol; 1986 Jun; 136(12):4531-7. PubMed ID: 3486901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The requirement for high intracellular cyclic adenosine monophosphate concentrations distinguishes two pathways of B cell activation induced with lymphokines and antibody to immunoglobulin.
    Hoffmann MK
    J Immunol; 1988 Jan; 140(2):580-2. PubMed ID: 2826594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of B-lymphocyte activation, proliferation, and immunoglobulin secretion.
    Paul WE; Mizuguchi J; Brown M; Nakanishi K; Hornbeck P; Rabin E; Ohara J
    Cell Immunol; 1986 Apr; 99(1):7-13. PubMed ID: 3093104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-gamma inhibits the action of B cell stimulatory factor (BSF)-1 on resting B cells.
    Rabin EM; Mond JJ; Ohara J; Paul WE
    J Immunol; 1986 Sep; 137(5):1573-6. PubMed ID: 3091686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of BSF-1 during an in vivo, T-dependent immune response.
    Finkelman FD; Ohara J; Goroff DK; Smith J; Villacreses N; Mond JJ; Paul WE
    J Immunol; 1986 Nov; 137(9):2878-85. PubMed ID: 3489779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for Lyb-2 in B cell activation mediated by a B cell stimulatory factor.
    Yakura H; Kawabata I; Ashida T; Shen FW; Katagiri M
    J Immunol; 1986 Sep; 137(5):1475-81. PubMed ID: 3091682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Separate control of B lymphocyte early activation and proliferation in response to anti-IgM antibodies.
    DeFranco AL; Raveche ES; Paul WE
    J Immunol; 1985 Jul; 135(1):87-94. PubMed ID: 3873499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of antigen-specific proliferation in affinity-purified small B lymphocytes: requirement for BSF-1 by type 2 but not type 1 thymus-independent antigens.
    Stein P; Dubois P; Greenblatt D; Howard M
    J Immunol; 1986 Mar; 136(6):2080-9. PubMed ID: 3081637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of B cell stimulatory factor 1/interleukin 4 in clonal proliferation of B cells.
    Peschel C; Green I; Ohara J; Paul WE
    J Immunol; 1987 Nov; 139(10):3338-47. PubMed ID: 3500217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B cell stimulatory factor 1 (interleukin 4) is a potent costimulant for normal resting T lymphocytes.
    Hu-Li J; Shevach EM; Mizuguchi J; Ohara J; Mosmann T; Paul WE
    J Exp Med; 1987 Jan; 165(1):157-72. PubMed ID: 3098893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isotype switching in anti-immunoglobulin-activated B lymphoblasts: differential requirements for interleukin 4 and other lymphokines to elicit membrane vs. secreted IgG1.
    Purkerson JM; Isakson PC
    Eur J Immunol; 1991 Mar; 21(3):707-14. PubMed ID: 2009912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection and characterization of a B cell stimulatory factor (BSF-TC) derived from a bone marrow stromal cell line.
    Simpson L; McNiece I; Newberg M; Schetz J; Lynch KR; Quesenberry P; Isakson PC
    J Immunol; 1989 Jun; 142(11):3894-900. PubMed ID: 2785568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B cell stimulatory factor-1 enhances the IgE response of lipopolysaccharide-activated B cells.
    Coffman RL; Ohara J; Bond MW; Carty J; Zlotnik A; Paul WE
    J Immunol; 1986 Jun; 136(12):4538-41. PubMed ID: 3486902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiimmunoglobulin-treated B cells respond to a B cell differentiation factor for IgG1.
    Isakson PC
    J Exp Med; 1986 Jul; 164(1):303-8. PubMed ID: 3088197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.